Ms Sherry K Foster, in Eminence, MO - Licensed Practical Nurse

Ms Sherry K Foster, is a Licensed Practical Nurse based in Eminence, Missouri. Ms Sherry K Foster is licensed to practice in Missouri (license number 046255) and her current practice location is 209 Main St., Eminence, Missouri. She can be reached at her office (for appointments etc.) via phone at (573) 226-5505.

NPI number for Ms Sherry K Foster is 1194837187 and her current mailing address is Rt.3 Box 17, Ellington, Missouri. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1194837187.

Contact Information

	Ms Sherry K Foster,
	209 Main St., Eminence, MO 65466
	(573) 226-5505
	(573) 226-5584

Provider's Profile

Full Name	Ms Sherry K Foster
Gender	Female
Speciality	Licensed Practical Nurse
Location	209 Main St., Eminence, Missouri
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1194837187
Provider Enumeration Date: 08/31/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Ms Sherry K Foster such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1194837187	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
164W00000X	Licensed Practical Nurse	046255 (Missouri)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Ms Sherry K Foster is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Ms Sherry K Foster, Rt.3 Box 17, Ellington, MO 63638 Ph: (573) 663-2724	Ms Sherry K Foster, 209 Main St., Eminence, MO 65466 Ph: (573) 226-5505

News Archive

Valeant subsidiary to acquire leading skin care brands in Australia

Valeant Pharmaceuticals International, Inc. announced today that its subsidiary, Biovail Laboratories International SRL (BLS), has agreed to acquire several privately–owned pharmacy skin care brands in Australia. The leading brands, including well-established local brands such as Hamilton's Suncare and Hamilton's Skin Therapy, are ranked #2 in suncare in the Australian pharmacy market.

NPS third quarter net loss increases to $15.7 million

NPS Pharmaceuticals, a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, today reported its results for the third quarter 2010.

Phase Forward, Quotient Clinical sign multi-year agreement

Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year agreement with Quotient Clinical, which specializes in early development services for a broad range of pharmaceutical and biotech customers.

Research suggests genetic predisposition to spontaneous coronary artery disease

A Mayo Clinic study has identified a familial association in spontaneous coronary artery dissection, a type of heart attack that most commonly affects younger women, suggesting a genetic predisposition to the condition, researchers say.

Study shows possibility to reduce antipsychotic use among nursing home residents with dementia

The use of antipsychotic medication in nearly 100 Massachusetts nursing homes was significantly reduced when staff was trained to recognize challenging behaviors of cognitively impaired residents as communication of their unmet needs, according to a new study led by Jennifer Tjia, MD, MSCE, associate professor of quantitative health sciences.

Ms Sherry K Foster, - Licensed Practical Nurse in Eminence, MO